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Comment on “Sexual
Maturation in Relation to
Polychlorinated Aromatic
Hydrocarbons: Sharpe and
Skakkebaek’s Hypothesis
Revisited”
The paper of Den Hond et al. (2002) is very
interesting, mainly because the reported
work demonstrates the potential of bio-
markers in environmental health programs.
However, we argue with the authors’ con-
clusion that their findings
suggest that, in line with the concept of endocrine
disruption and Sharpe and Skakkebaek’s hypothe-
sis [Sharpe and Skakkebaek 1993], environmental
exposure to PCAHs [polychlorinated aromatic
hydrocarbons] may adversely interfere with the
sexual maturation during the fetal and pubertal
stages of development.
The description of the project suggests
that the study was designed to investigate the
effects of incinerator emissions on the local
population in two suburbs of Antwerp,
Belgium, Wilrijk and Hoboken. However,
the study was part of a larger research project
commissioned by the Flemish government to
determine the feasibility and issues to be
considered in developing environmental
health monitoring. More particular, the
study of Den Hond et al (2002) was designed
to determine whether evaluation of biomark-
ers measured as part of the regular medical
examination of adolescents at the end of their
secondary education period would be feasi-
ble. We were asked by the Flemish govern-
ment to review the results of this project
(Cuijpers et al. 2000; Ghoetghebeur et al.
2000). We feel that the objectives and
hypotheses underlying a feasibility study
should not be convoluted with those relative
to the hypotheses arising from specific con-
cerns in certain a priori-defined regions. 
A major shortcoming of the design is
the lack of randomness regarding both the
study areas and the recruitment of the par-
ticipants. The study areas were well-known
polluted regions within the conurbation of
Antwerp. This knowledge may have influ-
enced the choice of tests to be performed.
Researchers should be cautious regarding a
priori choices of study areas, whether or not
the sponsor influences the choice. 
The use of volunteers instead of ran-
domly selected participants is another flaw,
introducing an extra risk of confounding. As
a consequence, for example, the proportion
of boys to girls in the three study areas dif-
fered considerably: from 0.7 to 3.0. In this
case there may have been a selection bias of
adolescents in lesser physical condition who
volunteered for examination.
Reported results were the outcome of
analyzing a multitude of associations among
the empirical data; they did not emerge after
a rigorous test of an a priori-formulated
hypothesis, at least not to our knowledge.
Such findings are valuable because they may
generate hypotheses for further research. In
this respect we agree with the authors’ clos-
ing sentence (Den Hond et al. 2002): 
… [F]urther studies should be undertaken to con-
firm or to refute our interpretation of the present
findings. 
The sexual development of the study
subjects was judged by the examining physi-
cians. The correspondence in ratings varied
between fair and good (as validated by kappa
coefficients) (Fleiss 1981). It is then impor-
tant to exclude a systematic over- or underes-
timation by one of the examining physicians.
This test was not been reported in the study. 
Finally, we would like to remark on the
reference the authors made (Den Hond
2002) to an earlier report on pregnancy
outcome in Flanders (Aelvoet et al 1999):
… [I]n 1997 the Flemish government reported a
higher percentage of medically assisted concep-
tions in the district around the waste incinerators
compared with the rest of Flanders.…
We feel that this report is incorrectly and
selectively referenced, suggesting that the
findings are in line with earlier results.
Taking into account the mother’s age, no
significant differences in way of delivery
were found in the earlier study (Aelvoet et al
1999). Furthermore, that report does not
contain statements about the necessity of
medical assistance at delivery. Part of the
above criticism was outlined in the review
reports (Cuijpers et al. 2000) but unfortu-
nately not addressed in the article by Den
Hond et al. (2002). 
To conclude, we would like to reiterate
that we commend the authors with their
highly relevant and extensive research work.
However, they should have placed their
study more clearly in the perspective of the
Flemish environmental health project. Their
conclusions generate interesting hypotheses
for further work but should not be viewed as
the results of a cause-and-effect study.
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“Sexual Maturation in
Relation to Polychlorinated
Aromatic Hydrocarbons…”:
Den Hond et al.’s Response
The Flemish Government commissioned
the Environment and Health Study after a
competitive call for research proposals in
1998 (Onderzoek Milieu en Gezondheid
1998). From the outset, this research project
included two distinct population-based sur-
veys, one in adolescents (16–18 years of age)
and another in adults (21–65 years of age).
We assume scientific responsibility only for
the project in adolescents.
Our study (which was carried out in
1999) sought to investigate whether, in ado-
lescents, biomarkers can show exposure to and
health effects of common environmental pol-
lutants (Staessen et al. 2001). We planned to
maximize the gradient in environmental expo-
sure by recruitment of adolescents from a
rural control area (Peer, Belgium) and a pol-
luted industrial suburb. For logistic reasons,
the adolescents were recruited from and were
examined at local schools. Life-long residence
in the study areas was a prerequisite for partic-
ipation. The Flemish Government imposed
the selection of the polluted area because of a
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impacts on public health of two waste incin-
erators in Wilrijk and a large nonferrous
smelter in Hoboken. Health authorities
assumed that our study would settle the local
concern about detrimental health outcomes
associated with the waste incinerators in
Wilrijk. In spite of the imposed selection of
the polluted area, our study had the advan-
tage of a clear-cut contrast in exposure
between the control and polluted areas, as
evidenced by all available records on environ-
mental monitoring. 
Molenberghs et al. found the lack of
randomness a major shortcoming of our
study design. However, they miscalculated
the proportion of boys to girls, which was
1.5 (60/40) in Peer, 1.0 (21/21) in Wilrijk,
and 2.1 (39/19) in Hoboken. We believe
that, in the context of the imposed selec-
tion, we maximally exploited the remaining
degrees of freedom to avoid serious selec-
tion bias. Indeed, participants and nonpar-
ticipants had similar age, sex distribution,
parental social class, and regional residence.
In the industrial suburb they resided at sim-
ilar distances from the main sources of pol-
lution, which strongly suggests random
selection with regard to exposure (Staessen
et al. 2001). Although we cannot extrapo-
late to the general Flemish population, our
conclusions are applicable to the adolescents
enrolled in our population-based sample. 
After our Data Monitoring Committee—
which was enlarged by three international
experts for peer-review—had discussed the
study outcomes on 12 May 2000, our results
became available for disclosure to the public
and subsequent scientific publication. The
health administration then appointed
Molenberghs and colleagues as the official
external reviewers of our study (Goetghebeur
et al. 2000; Cuijpers et al. 2000). These sta-
tisticians seem to imply that our conclusions
should have been restricted to the feasibility
of biomonitoring in adolescents and that we
should not have disclosed the unexpected
medical findings suggesting relevant environ-
mental health risks. To what extent their crit-
icisms are justified and independent remains
open for discussion. In this context, it is
interesting to note that, on 25 July 2000, the
Flemish Minister of Public Health addressed
a letter to the principal investigator of our
study (J.A.S.) demanding that disclosure of
the findings be postponed for 6 months until
the study in adults would be completed. This
embargo was lifted on 21 November 2000, a
few weeks after the municipal elections. 
In contrast to the criticism of Molenberghs
et al., we actually based our study on a priori
hypotheses associating defined biomarkers of
exposure with relevant effect markers (Staessen
et al. 2001). This is also the case for the specific
article on the endocrine effects of polychlori-
nated aromatic hydrocarbons (PCAHs) (Den
Hond et al. 2002) and other recent papers that
emanated from the adolescent study, for exam-
ple, those on the immune (Van Den Heuvel et
al. 2002) and genotoxic (Verheyen et al.
Unpublished data) effects. Because we were
concerned about the reproducibility of the stag-
ing of sexual maturation according to Marshall
and Tanner’s scale (Marshall and Tanner 1969;
Marshall and Tanner 1970) and the measure-
ment of testicular volume using Prader’s
orchidometer (Dörnberger et al. 1987), we
mounted a separate validation study of which
the results have been reported and discussed
elsewhere (Den Hond et al. 2001). 
Molenberghs et al. confuse medically
assisted conceptions with medically assisted
deliveries. Nevertheless, we acknowledge
that age is a major determinant of fertility in
women. However, the officially published
report did not include an age-adjusted
analysis of the proportion of medically
assisted conceptions (Advoet et al. 1999).
The median age in women at first delivery
was 27.3 (interquartile range 25.2–29.3)
years in Wilrijk and 26.6 (24.2–29.0) years
in Flanders. A difference of 0.7 years cannot
explain a 65–75% increase in medically
assisted conceptions (5.6% in Wilrijk vs.
3.4% in Flanders for singleton births and
59.0% vs. 33.4% for multiple births). 
We hope that, with these clarifications,
our study is more clearly placed in the per-
spective of the Flemish Environment and
Health Study. We agree with Molenberghs
et al. that our findings, although in line
with the concept of endocrine disruption
and Sharpe and Skakkebaek’s hypothesis,
require further research. As in all cross-sec-
tional epidemiologic studies, we did not
prove causation. However, numerous exper-
imental studies support the causal associa-
tion between exposure to PCAHs and
effects on sexual maturation. 
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Declaring Chemicals “Not
Carcinogenic to Humans”
Requires Validation, Not
Speculation 
Regulatory agencies should provide detailed
guidelines on how to use mechanistic and
epidemiologic data to dismiss positive cancer
evidence obtained from studies in experimen-
tal animals. Roberts and Ashby (2002)
bemoaned that the U.S. Environmental
Protection Agency (EPA) does not provide
opportunity to conclude that there is no evi-
dence of carcinogenicity from well-conducted
and adequately powered epidemiologic stud-
ies. In their letter, Roberts and Ashby pro-
vided examples for which they claimed that
there is enough information to draw valid
conclusions of “no effect.” Our examination
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Correspondenceof their examples and viewpoints reveals sev-
eral critical issues that they have ignored, but
which must be addressed in any future regula-
tory agency guidelines that may allow the dis-
missal of carcinogenic effects in animals based
on mechanistic and epidemiologic data. 
Roberts and Ashby (2002) appealed to
the International Agency for Research on
Cancer (IARC) guidelines (IARC 2000a) for
evaluating epidemiologic studies to rectify the
absence of procedures in the U.S. EPA’s
guidelines (US EPA 1999) that would allow
the conclusion that there is no carcinogenic
hazard based on well-conducted epidemio-
logic studies. However, Roberts and Ashby
disregarded the IARC distinction between
the classifications “inadequate evidence of
carcinogenicity” and “evidence suggesting
lack of carcinogenicity” in humans.
Requirements for the latter are intentionally
stringent, including multiple, mutually con-
sistent, adequately powered studies covering
the full range of human exposures that
exclude with reasonable certainty bias, con-
founding, and chance and provide individual
and pooled estimates of risk near unity with
narrow confidence intervals. In particular,
IARC (2000a) cautions that “latent periods
substantially shorter than 30 years cannot
provide evidence for lack of carcinogenicity.” 
With the IARC criteria in mind, it is sur-
prising that Roberts and Ashby (2002)
pointed to epidemiologic studies on clofibrate
as an example, where they claim there is suffi-
cient power to detect a cancer increase and
that there are enough data to conclude that
there is no carcinogenic effect. Although the
World Health Organization trial on preven-
tion of ischemic heart disease with clofibrate
includes 208,000 man-years of observation in
the mortality update (WHO 1984), the 5-
year treatment period plus the 8-year mortal-
ity follow-up period is insufficient to
adequately determine the extent of drug-
related cancer incidences or deaths, or to
make a valid conclusion of no risk of cancer.
Cancer is a group of diseases that most often
have latency periods greater than 20 years for
clinical manifestation. Further, because there
were only 206 total cancer deaths among the
5,331 men in the clofibrate group (WHO
1984), this study has inadequate power to
demonstrate lack of a carcinogenic hazard,
which should be evaluated for individual
sites. This study also provided no informa-
tion on cancer risk to women. The meta-
analysis by Law et al. (1994) did not provide
any estimates of cancer risk for clofibrate,
though it was cited by Roberts and Ashby
(2002) as part of the negative human evi-
dence on the carcinogenicity of this hypolipi-
demic drug. Certainly, exposure and
follow-up durations, gender differences, and
study power are critical issues for regulatory
agencies to address when formulating guide-
lines for use of epidemiologic studies to sup-
port a claim of no evidence of carcinogenicity
in humans despite positive cancer data in
experimental animals. 
On the use of mechanistic data for evalu-
ating chemical carcinogens, we have repeat-
edly stressed the need for rigorous testing of
mechanistic hypotheses (Huff 1995; Melnick
et al. 1997). In this regard it is instructive to
examine the basis for IARC’s conclusions on
the relevance of the carcinogenicity of peroxi-
some proliferators in experimental animals.
As noted by Roberts and Ashby (2002),
IARC opined that the mechanism of tumor
induction by clofibrate [and di(2-ethyl-
hexyl)phthalate (DEHP)] would not be oper-
ative in humans. For DEHP, there is
sufficient evidence of carcinogenicity in rats
and mice, yet IARC downgraded the classifi-
cation of this chemical from “possibly car-
cinogenic in humans” to “not classifiable as
to its carcinogenicity to humans” (IARC
2000b). Downgrading DEHP was based on
the working group’s conclusion that in addi-
tion to peroxisome proliferation, cell prolifer-
ation induced by DEHP is due to activation
of the peroxisome proliferator-activated
receptor (PPARα) and that peroxisome pro-
liferation had not been documented in
human hepatocyte cultures. However, in
considering IARC’s evaluation, it is impor-
tant to recognize that humans possess a func-
tional PPARα and that the working group
noted that effects of DEHP in human liver
have not been adequately evaluated. Cell pro-
liferation mediated by PPARα was consid-
ered by the IARC working group to be the
critical step in the carcinogenicity of peroxi-
some proliferators. 
Several deficiencies and critical data gaps
in the peroxisome proliferation mode-of-
action hypothesis have been noted (Melnick
2001). Moreover, recent studies have shown
that hepatocyte proliferation and peroxisome
proliferation occur by different mechanisms,
and that PPARα-independent effects that
occur in Kupffer cells are required for the
induction of cell proliferation and suppression
of apoptosis (Parzefall et al. 2001; Peters et al.
2001; Rose et al. 1999). Although the demon-
stration of the important role of Kupffer cells
in peroxisome proliferator-mediated effects is
fairly recent, it seems odd that this subject was
not mentioned in the IARC evaluation of
DEHP (IARC 2000b; Melnick 2003). Based
on current information, it is clear that peroxi-
some proliferators cause liver tumors in
rodents, but the mechanism of action is not
understood (Peters et al. 2001). 
Tomatis (2002) warned the occupational
and environmental health communities that
serious public health consequences might fol-
low if decision-making bodies rely on
untested mechanistic hypotheses that are
later shown experimentally to be incorrect.
Thus, when formulating guidelines for
acceptance of mechanistic hypotheses, we
expect regulatory agencies to require rigorous
testing and validation before using incom-
plete data sets to downgrade the categoriza-
tion of chemical carcinogens. Such
guidelines must also address whether differ-
ences in mechanistic events among species
are truly qualitative rather than quantitative
in nature. For quantitative differences, the
guidelines should also require information
on the range of parameter variability in
exposed humans so that sensitive subpopula-
tions are not ignored in these categorizations.
The issue is not singularly the adequacy of
mechanistic or epidemiologic evidence, but
certainty for protecting public health.
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